Sphingosine-1-phosphate induces contraction of valvular interstitial cells from porcine aortic valves

Cardiovascular Research

Volumn 93, Issue 3, 2012, Pages 490-497

  Witt, Wolfgang ^a   Jannasch, Anett ^a   Burkhard, Daniela ^a   Christ, Torsten ^a   Ravens, Ursula ^a   Brunssen, Coy ^a   Leuner, Anja ^a   Morawietz, Henning ^a   Matschke, Klaus ^a   Waldow, Thomas ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aortic valve; RhoA; Sphingosine 1 phosphate; Valve contraction; Valvular interstitial cell

Indexed keywords

ADRENALIN; CALCIUM ION; PROTEIN KINASE; RHOA ASSOCIATED PROTEIN KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE 1; SPHINGOSINE 1 PHOSPHATE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL POPULATION; CELLS; CYTOSOL; HEART CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SWINE; VALVULAR INTERSTITIAL CELL;

ANIMALS; AORTIC VALVE; CALCIUM; CELLS, CULTURED; EPINEPHRINE; GENE EXPRESSION; ISOMETRIC CONTRACTION; LYSOPHOSPHOLIPIDS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, LYSOSPHINGOLIPID; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SPHINGOSINE; STRESS, MECHANICAL; SUS SCROFA;

EID: 84857600083     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs002     Document Type: Article

References (44)

1. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. Int J Biochem Cell Biol 2003;35:113-118.
2. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007;171:1407-1418.
3. Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008;118:1864-1880.
4. Butcher JT, Simmons CA, Warnock JN. Mechanobiology of the aortic heart valve. J Heart Valve Dis 2008;17:62-73.
5. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006;113:1344-1352.
6. Benton JA, Kern HB, Leinwand LA, Mariner PD, Anseth KS. Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol 2009;29:1950-1957.
7. Gu X, Masters KS. Role of the MAPK/ERK pathway in valvular interstitial cell calcification. Am J Physiol Heart Circ Physiol 2009;296:H1748-H1757.
8. Gu X, Masters KS. Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation. Am J Physiol Heart Circ Physiol 2011;300:H448-H458.
9. Filip DA, Radu A, Simionescu M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 1986;59:310-320.
10. Chester AH, Misfeld M, Yacoub MH. Receptor-mediated contraction of aortic valve leaflets. J Heart Valve Dis 2000;9:250-254.
11. Bowen IM, Marr CM, Chester AH, Wheeler-Jones CP, Elliott J. In-vitro contraction of the equine aortic valve. J Heart Valve Dis 2004;13:593-599.
12. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarathchandra P, Taylor PM et al. Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol 2009;53:1448-1455.
13. El-Hamamsy I, Yacoub MH, Chester AH. Neuronal regulation of aortic valve cusps. Curr Vasc Pharmacol 2009;7:40-46.
14. Warnock JN, Gamez CA, Metzler SA, Chen J, Elder SH, Liao J. Vasoactive agents alter the biomechanical properties of aortic heart valve leaflets in a time-dependent manner. J Heart Valve Dis 2010;19:86-95.
15. Hutcheson JD, Setola V, Roth BL, Merryman WD. Serotonin receptors and heart valve disease-it was meant 2B. Pharmacol Ther 2011;132:146-157.
16. Watterson KR, Ratz PH, Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal 2005;17:289-298.
17. Watterson KR, Lanning DA, Diegelmann RF, Spiegel S. Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen 2007;15:607-616.
18. Schuchardt M, Tolle M, Prufer J, van der Giet M. Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. Br J Pharmacol 2011;163:1140-1162.
19. Takuwa Y, Okamoto Y, Yoshioka K, Takuwa N. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. Biochim Biophys Acta 2008;1781:483-488.
20. Skoura A, Hla T. Regulation of vascular physiology and pathology by the S1P2 receptor subtype. Cardiovasc Res 2009;82:221-228.
21. Means CK, Brown JH. Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 2009;82:193-200.
22. Karliner JS. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J Cardiovasc Pharmacol 2009;53:189-197.
23. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 2007;115:84-105.
24. Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S. Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem 2009;78:743-768.
25. Stephens EH, Carroll JL, Grande-Allen KJ. The use of collagenase III for the isolation of porcine aortic valvular interstitial cells: Rationale and optimization. J Heart Valve Dis 2007;16:175-183.
26. Goettsch C, Goettsch W, Brux M, Haschke C, Brunssen C, Muller G et al. Arterial flow reduces oxidative stress via an antioxidant response element and Oct-1 binding site within the NADPH oxidase 4 promoter in endothelial cells. Basic Res Cardiol 2011;106:551-561.
27. Waldow T, Witt W, Ulmer A, Janke A, Alexiou K, Matschke K. Preconditioning by inhaled nitric oxide prevents hyperoxic and ischemia/reperfusion injury in rat lungs. Pulm Pharmacol Ther 2008;21:418-429.
28. 1- adrenoceptors in human atrial myocardium. Naunyn Schmiedbergs Arch Pharmacol 2006;374:249-253.
29. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004;95:253-260.
30. Latif N, Sarathchandra P, Taylor PM, Antoniw J, Brand N, Yacoub MH. Characterization of molecules mediating cell-cell communication in human cardiac valve interstitial cells. Cell Biochem Biophys 2006;45:255-264.
31. Pho M, Lee W, Watt DR, Laschinger C, Simmons CA, McCulloch CA. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am J Physiol Heart Circ Physiol 2008;294:H1767-H1778.
32. Long JS, Fujiwara Y, Edwards J, Tannahill CL, Tigyi G, Pyne S et al. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J Biol Chem 2010;285:35957-35966.
33. Salomone S, Potts EM, Tyndall S, Ip PC, Chun J, Brinkmann V et al. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 2008;153:140-147.
34. Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 2010;11:353-365.
35. Murata N, Sato K, Kon J, Tomura H, Okajima F. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. Anal Biochem 2000;282:115-120.
36. Takuwa N, Du W, Kaneko E, Okamoto Y, Yoshioka K, Takuwa Y. Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1. Am J Cancer Res 2011;1:460-481.
37. Essler M, Retzer M, Ilchmann H, Linder S, Weber PC. Sphingosine 1-phosphate dynamically regulates myosin light chain phosphatase activity in human endothelial cells. Cell Signal 2002;14:607-613.
38. Zhou H, Murthy KS. Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am J Physiol Cell Physiol 2004;286:C1130-C1138.
39. Liang W, McDonald P, McManus B, van BC, Wang X. Histamine-induced Ca (2+) signaling in human valvular myofibroblasts. J Mol Cell Cardiol 2003;35:379-388.
40. Yip CY, Simmons CA. The aortic valve microenvironment and its role in calcific aortic valve disease. Cardiovasc Pathol 2011;20:177-182.
41. Yip CY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 2009;29:936-942.
42. Kloxin AM, Benton JA, Anseth KS. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 2010;31:1-8.
43. Chester AH. Endothelin-1 and the aortic valve. Curr Vasc Pharmacol 2005;3:353-357.
44. Chester AH, Misfeld M, Sievers HH, Yacoub MH. Influence of 5-hydroxytryptamine on aortic valve competence in vitro. J Heart Valve Dis 2001;10:822-825.